Live Breaking News & Updates on Alembic pharmaceuticals ltd

Stay informed with the latest breaking news from Alembic pharmaceuticals ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Alembic pharmaceuticals ltd and stay connected to the pulse of your community

Share Market Highlights 24 April 2024: Sensex gains 114 pts, Nifty settles above 22,400

Share Market Highlights 24 April 2024: Sensex gains 114 pts, Nifty settles above 22,400
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Laos , Haryana , India , Thiruvananthapuram , Kerala , Tamil-nadu , Hindustan , India-general- , Russia , Israel , Gargi , Jharkhand

Stock Market Live Updates 23 April, 2024: Sensex, Nifty open on a firm note

Stock Market Live Updates 23 April, 2024: Sensex, Nifty open on a firm note
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Coromandel , India-general- , India , Hindustan , Bhiwandi , Maharashtra , Tamilnad , Tamil-nadu , Nigeria , United-states , Israel , Tehran

Share Market Highlights 23rd April 2024: Sensex, Nifty hold steady; Sensex rises 89 points to 73,857, Nifty 50 rises 31.60 pts to 22368

Share Market Highlights 23rd April 2024: Sensex, Nifty hold steady; Sensex rises 89 points to 73,857, Nifty 50 rises 31.60 pts to 22368
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Nigeria , Jordan , Israel , Chhattisgarh , India , Germany , Texas , United-states , Mexico , Mumbai , Maharashtra , Sanghi

USFDA gives nod to Alembic Pharma's breast cancer drug - Pharma News

USFDA gives nod to Alembic Pharma's breast cancer drug - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Novarti-kisqali , Us-food-drug-administration , Alembic-pharmaceuticals-ltd-on , Alembic-pharmaceuticals , Alembic-pharmaceuticals-ltd , Drug-administration ,

Stocks that will see action today: March 11, 2024 - The Hindu BusinessLine

Stocks that will see action today: March 11, 2024 - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Delhi , India , Ahmedabad , Gujarat , Ukraine , United-states , Mumbai , Maharashtra , Tamil-nadu , Telangana , Andhra-pradesh , Surajpur

Obsessive-Compulsive Disorder Drugs Market size worth USD 348.54 million, 55% Growth to Originate from North America

/PRNewswire/ -- The obsessive-compulsive disorder drugs market is anticipated to grow by USD 348.54 million, progressing at a CAGR of 5.93% during the forecast...

Canada , United-states , United-kingdom , Japan , America , American , Kabir-lifesciences , Eli-lilly , Jesse-maida , Wellona-pharma , Omeros-corp , Technavio-research

Stock Market Live Updates: Sensex and Nifty turn volatile despite positive start; analysts warn of increased selling

Stock Market Live Updates: Sensex and Nifty turn volatile despite positive start; analysts warn of increased selling
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Ukraine , Canada , Mauritius , Rajkot , Gujarat , India , Australia , Kolkata , West-bengal , Jaipur

Honeywell, Adani and more: 10 biggest midcap losers of Nifty 50 in 2023

While Nifty has seen one of its most successful years in 2023, here are the biggest midcap losers on the index this year.

Canara , Karnataka , India , Bajaj-finserv , Adani-wilmar , Bloomberg , Page-industries , Rajesh-exports-ltd , Canara-bank , Honeywell-automation-india-ltd , Atul-ltd-on , Sumitomo-chemical-india-ltd

Govt Bans Common Cold And Flu Syrups For Kids Below 4 Yrs, Asks Pharma Companies To Insert Warnings

Pharma firms manufacturing GlaxoSmithKline’s T-Minic Oral Drops, Glenmark’s Ascoril Flu Syrup, and IPCA Laboratories’ Solvin Cold Syrup, among others, have been asked by the regulator to insert a ‘warning’. - Govt Bans Common Cold And Flu Syrups For Kids Below 4 Yrs, Asks Pharma Companies To Insert Warnings | Check List

New-delhi , Delhi , India , Rajeev-singh-raghuvanshi , Ipca-laboratories-ltd-solvin-cold , Glenmark-pharmaceuticals-ltd-ascoril-flu , Alembic-pharmaceuticals-ltd-wikoryl , Wanbury-ltd-coriminic , Glaxo-smithkline-pharmaceuticals-ltdt-minic , World-health-organization , Union-territories , Central-drugs-standard-control-organisation

CDSCO to ban common cold and flu syrups for children below four years; Pharma cos asked to insert warning

CDSCO to ban common cold and flu syrups for children below four years; Pharma cos asked to insert warning
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Rajeev-singh-raghuvanshi , Expert-committee , Ipca-laboratories-ltd-solvin-cold , Union-territory , Glenmark-pharmaceuticals-ltd-ascoril-flu , Alembic-pharmaceuticals-ltd-wikoryl , Wanbury-ltd-coriminic , Committee-on , Glaxo-smithkline-pharmaceuticals-ltdt-minic , Central-drugs-standard-control-organisation , Subject-expert-committee , Chlorpheniramine-maleate